Yuhan Corp. (KO:000100) — Market Cap & Net Worth
Market Cap & Net Worth: Yuhan Corp. (000100)
Yuhan Corp. (KO:000100) has a market capitalization of $3.86 Billion (₩5.69 Trillion) as of September 18, 2026. Listed on the KO stock exchange, this Korea-based company holds position #4212 globally and #95 in its home market, demonstrating a -2.28% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Yuhan Corp.'s stock price ₩77300.00 by its total outstanding shares 73615781 (73.62 Million). Also see 000100 total asset value for a full breakdown of the balance sheet.
Yuhan Corp. Market Cap History: 2015 to 2026
Yuhan Corp.'s market capitalization history from 2015 to 2026. Data shows growth from $1.74 Billion to $3.86 Billion (8.05% CAGR). Also see cash flow conversion of Yuhan Corp. for how efficiently the company converts equity into cash flow.
Yuhan Corp. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Yuhan Corp.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check 000100 stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.00x
Yuhan Corp.'s market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.03x
Yuhan Corp.'s market cap is 0.03 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.35 Billion | $1.32 Trillion | $161.25 Billion | 0.00x | 0.01x |
| 2017 | $1.57 Billion | $1.46 Trillion | $109.03 Billion | 0.00x | 0.01x |
| 2018 | $1.55 Billion | $1.52 Trillion | $57.48 Billion | 0.00x | 0.03x |
| 2019 | $1.90 Billion | $1.48 Trillion | $40.01 Billion | 0.00x | 0.05x |
| 2020 | $3.19 Billion | $1.62 Trillion | $192.76 Billion | 0.00x | 0.02x |
| 2021 | $2.79 Billion | $1.69 Trillion | $102.58 Billion | 0.00x | 0.03x |
| 2022 | $2.72 Billion | $1.78 Trillion | $95.14 Billion | 0.00x | 0.03x |
| 2023 | $3.43 Billion | $1.86 Trillion | $136.20 Billion | 0.00x | 0.03x |
| 2024 | $5.96 Billion | $2.07 Trillion | $70.69 Billion | 0.00x | 0.08x |
| 2025 | $5.61 Billion | $2.19 Trillion | $194.08 Billion | 0.00x | 0.03x |
Competitor Companies of 000100 by Market Capitalization
Companies near Yuhan Corp. in the global market cap rankings as of September 18, 2026. Review how tangible is Yuhan Corp.'s equity to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Yuhan Corp. by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #519 globally with a market cap of $52.60 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #633 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #640 globally with a market cap of $43.16 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #670 globally with a market cap of $40.62 Billion USD ( CN¥277.61 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #519 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #633 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.00 |
| #640 | GALDERMA GROUP AG | NYSE:GALDY | $43.16 Billion | $37.02 |
| #670 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $40.62 Billion | CN¥43.52 |
Yuhan Corp. Historical Marketcap From 2015 to 2026
Between 2015 and today, Yuhan Corp.'s market cap moved from $1.74 Billion to $ 3.86 Billion, with a yearly change of 8.05%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩3.86 Billion | -31.23% |
| 2025 | ₩5.61 Billion | -5.94% |
| 2024 | ₩5.96 Billion | +73.69% |
| 2023 | ₩3.43 Billion | +26.29% |
| 2022 | ₩2.72 Billion | -2.57% |
| 2021 | ₩2.79 Billion | -12.60% |
| 2020 | ₩3.19 Billion | +67.63% |
| 2019 | ₩1.90 Billion | +22.53% |
| 2018 | ₩1.55 Billion | -0.96% |
| 2017 | ₩1.57 Billion | +16.39% |
| 2016 | ₩1.35 Billion | -22.62% |
| 2015 | ₩1.74 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 17th, 2026 the market cap of Yuhan Corp. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.86 Billion USD |
| MoneyControl | $3.86 Billion USD |
| MarketWatch | $3.86 Billion USD |
| marketcap.company | $3.86 Billion USD |
| Reuters | $3.86 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Yuhan Corp.
Yuhan Corporation operates as a pharmaceutical company in South Korea and internationally. It offers manufacturing services, such as custom manufacturing; process research and development of active pharmaceutical products (APIs) and intermediates; kilo and pilot-scale production of APIs and intermediates; commercial production of APIs and intermediates; production of chemical specialties; and ana… Read more